
Apollo Endosurgery APEN
Annual report 2022
added 03-30-2023
Apollo Endosurgery Operating Cycle 2011-2026 | APEN
Annual Operating Cycle Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220 | 198 | 261 | 196 | 199 | 280 | 235 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 280 | 196 | 227 |
Quarterly Operating Cycle Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 116 | - | 216 | - | 202 | 187 | 208 | - | 220 | 425 | 246 | - | 214 | 173 | 215 | - | 215 | 203 | 236 | - | 282 | 260 | 307 | - | 272 | 176 | 291 | - | 10.4 | 0.85 | 42.7 | - | 59.8 | 49.8 | 54.1 | - | 46.9 | 59.3 | 63.4 | - | 15 | 16.1 | 25.9 | - | 68.5 | 79 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 425 | 0.85 | 155 |
Operating Cycle of other stocks in the Medical devices industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aziyo Biologics
AZYO
|
160 | - | 1.37 % | $ 20.5 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
159 | - | - | $ 1.77 B | ||
|
Conformis
CFMS
|
216 | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
274 | $ 39.26 | -0.03 % | $ 5.85 K | ||
|
Lianluo Smart Limited
LLIT
|
128 | - | 24.59 % | $ 44.8 M | ||
|
Cardiovascular Systems
CSII
|
254 | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
462 | - | -10.19 % | $ 1.99 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
194 | - | -5.86 % | $ 30.6 M | ||
|
Acutus Medical
AFIB
|
853 | - | -26.83 % | $ 2.62 M | ||
|
Dynatronics Corporation
DYNT
|
133 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
156 | - | - | $ 10.2 M | ||
|
Cognyte Software Ltd.
CGNT
|
76.7 | $ 8.01 | 2.43 % | $ 575 M | ||
|
Allied Healthcare Products
AHPI
|
294 | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
224 | - | -0.97 % | $ 54.4 M | ||
|
AdaptHealth Corp.
AHCO
|
64 | $ 9.63 | 2.39 % | $ 1.3 B | ||
|
EDAP TMS S.A.
EDAP
|
163 | $ 4.17 | 4.51 % | $ 155 M | ||
|
CONMED Corporation
CNMD
|
270 | $ 43.47 | 0.36 % | $ 1.35 B | ||
|
Electromed
ELMD
|
228 | $ 24.2 | 0.92 % | $ 205 M | ||
|
CryoLife, Inc.
CRY
|
212 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
381 | - | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
279 | $ 29.57 | -0.87 % | $ 1.36 B | ||
|
Apyx Medical Corporation
APYX
|
299 | $ 3.22 | 1.58 % | $ 111 M | ||
|
Axonics Modulation Technologies
AXNX
|
339 | - | - | $ 3.31 B | ||
|
FONAR Corporation
FONR
|
251 | $ 18.55 | 0.27 % | $ 122 M | ||
|
Soliton, Inc.
SOLY
|
455 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | ||
|
Accuray Incorporated
ARAY
|
233 | $ 0.52 | -1.73 % | $ 53.4 M | ||
|
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
130 | - | - | $ 111 M | ||
|
Medigus Ltd.
MDGS
|
411 | - | 10.28 % | $ 55.5 M | ||
|
Cytosorbents Corporation
CTSO
|
175 | $ 0.79 | -1.52 % | $ 43 M | ||
|
Align Technology
ALGN
|
171 | $ 183.62 | 0.54 % | $ 13.7 B | ||
|
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | ||
|
Inari Medical
NARI
|
268 | - | - | $ 4.23 B | ||
|
Butterfly Network
BFLY
|
866 | $ 3.94 | 6.35 % | $ 834 M | ||
|
BIOLASE
BIOL
|
196 | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
181 | $ 113.39 | -0.17 % | $ 197 B | ||
|
NuVasive
NUVA
|
425 | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
359 | - | - | $ 217 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
169 | $ 72.39 | -1.98 % | $ 107 B | ||
|
InMode Ltd.
INMD
|
307 | $ 13.53 | -0.51 % | $ 874 M | ||
|
Helius Medical Technologies
HSDT
|
381 | $ 2.14 | 8.08 % | $ 1.3 M | ||
|
Alphatec Holdings
ATEC
|
314 | $ 12.99 | -0.23 % | $ 1.95 B | ||
|
IRIDEX Corporation
IRIX
|
170 | $ 1.42 | -0.7 % | $ 22.9 M | ||
|
IRadimed Corporation
IRMD
|
308 | $ 105.43 | 1.09 % | $ 1.34 B | ||
|
Edwards Lifesciences Corporation
EW
|
341 | $ 85.35 | 0.1 % | $ 49.9 B |